PT KIMIA FARMA (PERSERO) Tbk I C A R E I C A R E PT KIMIA FARMA (PERSERO) Tbk Jl. Veteran no. 9, Jakarta 10110 Telp. (021) 384 7709 Fax. (021) 381 4441 Email: [email protected] Website: www.kimiafarma.co.id Kinerja KAEF KAEF Performance 148,17% Kapitalisasi Pasar Meningkat Kapitalisasi pasar saham meningkat 148,17% dari Rp3,28 triliun Market Capitalization Increased pada tahun 2013 menjadi Rp8,14 triliun pada tahun 2014. Stock market capitalization increased by 148.17%, from IDR3.28 trillion in 2013 to IDR8,14 trillion in 2014. 20,08% Aset Meningkat Aset meningkat 20,08% dari Rp2,47 triliun pada tahun 2013 menjadi Assets Increased Rp2,97 triliun pada tahun 2014. Asset increased by 20.08%, from IDR2.47 trillion in 2013 to IDR2.97 trillion in 2014. 16,58% Laba Usaha Meningkat Laba usaha meningkat 16,58% dari Rp293,77 miliar menjadi Rp342,48 Operational Profit Increased miliar. Operational profit increased by 16,58%, from IDR293,77 billion in 2013 to IDR342,48 billion in 2014. 9,36% Laba Bersih Meningkat Laba bersih meningkat 9,36% dari Rp214,55 miliar pada tahun 2013 Net Profit Increased menjadi Rp234,63 miliar pada tahun 2014 dan melebihi anggaran 0,51%. Net profit increased by 9.36%, from IDR214.55 billion in 2013 to IDR234.63 billion in 2014, which exceeded the Budget by 0.51%. 45,47% Kas Meningkat Kas meningkat 45,47% dari Rp394,15 miliar pada tahun 2013 menjadi Cash Increased Rp573,36 miliar pada tahun 2014. Cash increased by 45.47%, from IDR394.15 billion in 2013 to IDR573.36 billion in 2014. 3,98% Penjualan Meningkat Penjualan meningkat 3,98% dari Rp4,35 triliun pada tahun 2013 menjadi Sales Increased Rp4,52 triliun pada tahun 2014, dan tercapai 87,78% dari anggaran. Sales increased by 3.98%, from IDR4.35 trillion in 2013 to IDR4.52 trillion in 2014, which achieved 87.7% of the Budget. Produk Perseroan baik bahan baku, sediaan farmasi dan produk obat jadi diekspor ke beberapa negara antara lain: Eropa, Asia, Selandia Baru dan Uni Emirat Arab. The Company’s products which includes raw materials, pharmaceutical preparations and patent medicine are exported to several countries including Europe, Asia, New Zealand and United Arab Emirates. Daftar Isi Table of Contents Kinerja KAEF i KAEF Performance Ikhtisar Keuangan 1 Financial Highlights Perdagangan Saham KAEF 3 KAEF Stocks Trading Aksi Korporasi 4 Corporate Action Profil Perseroan 7 Company Profile Penghargaan 14 Awards Peristiwa Penting 16 Event Highlights Laporan Manajemen 19 Management’s Reports Bidang dan Kegiatan Usaha 33 Business Sectors and Activities Organisasi 51 The Organization Analisa dan Tinjauan Manajemen atas Kinerja Perusahaan 67 Management’s Discussion and Analysis on the Company’s Performance Tata Kelola Perusahaan 111 Good Corporate Governance Tanggung Jawab Sosial Perseroan 165 Corporate Social Responsibility Laporan Tahunan 2014 PT Kimia Farma (Persero) Tbk iii PT Kimia Farma (Persero) Tbk Annual Report 2014 Kinerja KAEF i KAEF Performance Ikhtisar Keuangan 1 Financial Highlights Ikhtisar Keuangan Perdagangan Saham KAEF 3 KAEF Stocks Trading Financial Highlights Aksi Korporasi 4 Corporate Action Profil Perseroan 7 Company Profile Penghargaan 14 Awards Peristiwa Penting 16 Event Highlights Laporan Manajemen 19 Management’s Reports Bidang dan Kegiatan Usaha 33 Business Sectors and Activities Organisasi 51 The Organization Analisa dan Tinjauan Manajemen atas Kinerja Perusahaan 67 Management’s Discussion and Analysis on the Company’s Performance Tata Kelola Perusahaan 111 Good Corporate Governance Tanggung Jawab Sosial Perseroan 165 Corporate Social Responsibility Laporan Tahunan 2014 PT Kimia Farma (Persero) Tbk PT Kimia Farma (Persero) Tbk Annual Report 2014 1 Ikhtisar Keuangan Financial Highlights Neraca, Laporan Laba Rugi & Rasio-Rasio Keuangan 2010-2014 Balance Sheet, Loss Profit Statements & Financial Ratios 2010-2014 2014 2013 2012 2011 2010 NERACA (dalam juta rupiah) Balance Sheet (in million rupiah) KAS Cash 573.360 394.150 316.498 199.386 265.446 PIUTANG DAGANG Account Receivable 514.930 546.576 458.728 384.037 357.712 TOTAL ASET LANCAR Total Current Asset 2.040.431 1.810.615 1.505.798 1.263.030 1.139.549 TOTAL ASET TETAP Total Fixed Asset 557.939 498.644 449.140 426.720 413.197 TOTAL ASET Total Assets 2.968.185 2.471.940 2.076.348 1.794.400 1.657.292 UTANG USAHA Account Payable 505.219 477.892 341.133 284.234 300.987 TOTAL LIABILITAS LANCAR Total Current Liability 854.812 746.123 537.184 459.694 469.823 TOTAL LIABILITAS TIDAK LANCAR Total Non-Current Liability 302.229 101.462 97.630 82.043 73.435 TOTAL LIABILITAS Total Liability 1.157.041 847.585 634.814 541.737 543.257 JUMLAH EKUITAS Total Equity 1.789.213 1.608.225 1.426.497 1.252.660 1.114.034 JUMLAH INVESTASI Total Investment 349.270 199.269 81.802 42.334 38.353 MODAL KERJA BERSIH Net Working Capital 1.185.618 1.064.492 968.614 803.336 669.726 LAPORAN LABA RUGI (dalam juta rupiah) Loss Profit Statements (in million rupiah) TOTAL PENJUALAN Total Sales 4.521.024 4.348.074 3.734.241 3.481.166 3.183.829 LABA KOTOR Gross Profit 1.385.482 1.292.152 1.175.167 1.038.016 904.519 TOTAL BEBAN USAHA Total Operating Expense 1.099.831 1.042.619 912.599 816.012 758.321 LABA USAHA Operating Profit 342.480 293.765 262.567 222.003 146.198 LABA (RUGI) SEBELUM PAJAK Profit (Loss) Before Tax 315.611 284.125 278.284 232.007 178.611 LABA (RUGI) BERSIH Net Profit (Loss) 234.625 214.550 205.133 171.765 138.716 LABA (RUGI) BERSIH PER SAHAM (rupiah) Net Profit (Loss) per Share (rupiah) 42.24 38.63 36.93 30.93 24.98 RASIO-RASIO KEUANGAN Financial Ratios IMBAL HASIL Investasi (%) Return on Investment 11,54 11,88 13,73 13,60 11,64 IMBAL HASIL Ekuitas (%) Return on Equity 13,11 13,34 14,38 13,71 12,45 IMBAL HASIL ASET (%) Return on Asset 7,90 8,68 9,88 9,57 8,37 MARGIN LABA KOTOR (%) Gross Profit Margin 30,65 29,72 31,47 29,82 28,41 MARGIN LABA BERSIH (%) Net Profit Margin 5,19 4,93 5,49 4,93 4,36 RASIO Perputaran ASET (%) Asset Turnover Ratio 166,21 191,20 179,66 201,72 197,56 RASIO LANCAR Current Ratio 2,39 2,43 2,80 2,75 2,43 RASIO Cepat Quick Ratio 1,58 2,43 1,82 1,76 1,60 RASIO Utang JANGKA PANJANG (%) Long Term Debt Ratio 26,12 11,97 15,38 15,14 13,52 RASIO Liabilitas TERHADAP JUMLAH ASET (%) Liability to Total Asset Ratio 38,98 34,29 30,57 30,19 32,78 RASIO Liabilitas TERHADAP Ekuitas (%) Liability to Equity Ratio 64,67 52,70 44,50 43,25 48,77 Laporan Tahunan 2014 PT Kimia Farma (Persero) Tbk 2 PT Kimia Farma (Persero) Tbk Annual Report 2014 Ikhtisar Keuangan Financial Highlights Perdagangan Saham KAEF KAEF Stocks Trading Perdagangan Saham Periode Januari 2013–Desember 2014 Stocks Trading on January 2013–December 2014 Period Harga Pasar Peredaran Saham di Pasar Reguler Market Price Circulation of Shares in Reguler Market Bulan Tertinggi Terendah Terakhir Volume Nilai Frekuensi Kapitalisasi Pasar Month Highest Lowest Closing Volume Value Frequency Market Capitalisation 2013 (Rp) (Rp) (Rp) Unit (Rp) (x) (Rp) JANUARY 1.050 710 1.030 228.826.500 204.015.095.000 7.751 5.720.620.000.000 FEBRUARY 1.140 970 1.090 164.549.500 173.411.465.000 8.250 6.053.860.000.000 MARCH 1.160 1.030 1.080 175.271.500 191.570.965.000 13.433 5.998.320.000.000 APRIL 1.090 960 990 94.964.500 96.641.465.000 6.022 5.498.460.000.000 MAY 1.040 890 960 116.944.500 113.346.465.000 7.149 5.331.840.000.000 JUNE 980 840 890 49.458.500 44.953.415.000 4.125 4.943.060.000.000 JULY 910 790 790 22.850.500 19.658.215.000 2.558 4.378.660.000.000 AUGUST 810 460 495 76.763.500 41.238.545.000 9.458 2.749.230.000.000 SEPTEMBER 670 420 550 94.478.000 51.744.732.500 5.800 3.054.700.000.000 OCTOBER 720 520 630 56.331.000 34.805.015.000 3.862 3.449.020.000.000 NOVEMBER 640 480 510 46.586.000 26.214.622.500 3.276 2.832.540.000.000 DECEMBER 590 495 590 45.656.500 24.422.450.000 2.730 3.276.860.000.000 Total 1.172.680.500 1.022.022.450.000 74.414 53.287.170.000.000 2014 (Rp) (Rp) (Rp) Unit (Rp) (x) (Rp) JANUARY 745 745 690 133.610 1.441.596.000 11.212 3.832.260.000.000 FEBRUARY 795 795 750 123.927 1.568.463.500 9.404 4.165.500.000.000 MARCH 925 925 900 140.408 1.844.259.000 10.873 4.998.600.000.000 APRIL 945 945 915 72.488 2.352.240.000 7.568 5.081.910.000.000 MAY 1.055 1.055 1.050 119.535 7.969.907.500 10.197 5.831.700.000.000 JUNE 1.090 1.090 990 71.768 2.026.103.000 8.407 5.498.460.000.000 JULY 1.270 1.270 1.230 133.964 3.728.017.000 8.741 6.831.420.000.000 AUGUST 1.370 1.370 1.320 4.444.800 5.815.633.500 7.024 7.331.280.000.000 SEPTEMBER 1.370 1.370 1.150 276.300 317.153.000 4.671 6.387.100.000.000 OCTOBER 1.210 1.210 1.115 7.803.200 8.992.367.500 6.046 6.192.710.000.000 NOVEMBER 1.405 1.405 1.390 2.183.400 2.971.494.500 8.088 7.720.060.000.000 DECEMBER 1.640 1.640 1.465 1.361.700 1.989.251.500 13.889 8.136.610.000.000 Total 16.865.100 41.016.486.000 105.749 72.007.610.000.000 Pergerakan Saham Januari 2013–Desember 2014 Stocks Movement on January 2013–December 2014 Market Cap 2013 2014 Price 1.600 9.000.000.000.000 1.465 1.390 1.400 1.320 8.000.000.000.000 1.230 1.150 1.155 7.000.000.000.000 1.200 1.090 1.080 1.030 1.055 990 6.000.000.000.000 990 1.000 960 900 915 890 790 5.000.000.000.000 750 800 690 630 550 4.000.000.000.000 590 600 510 495 3.000.000.000.000 400 2.000.000.000.000 200 1.000.000.000.000 Jan Feb Mar Apr Mei Jun Jul Agu Sep Okt Nov Des Jan Feb Mar Apr Mei Jun Jul Agu Sep Okt Nov Des ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘13 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 ‘14 Laporan Tahunan 2014 PT Kimia Farma (Persero) Tbk PT Kimia Farma (Persero) Tbk Annual Report 2014 3 Aksi Korporasi Corporate Action Pada tahun 2014, Perseroan memiliki 2 (dua) aksi In 2014, there were 2 (two) corporate actions applied by korporasi yaitu penerbitan Surat Utang Jangka Menengah the Company, namely Medium Term Notes issuance and (Medium Term Notes/MTN) dan penyertaan saham 10% investment in share at PT Asuransi Jiwa InHealth PT Asuransi Jiwa InHealth Indonesia sebesar 10%.